West Nile Elisa Kit
Lab Reagents
Human IgG antibody Laboratories manufactures the west nile elisa kit reagents distributed by Genprice. The West Nile Elisa Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact nile elisa. Other West products are available in stock. Specificity: West Category: Nile Group: Elisa Kit
West Nile Virus Envelope Peptide |
|||
3437P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) West Nile Virus Envelope peptide |
West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Peptide |
|||
3439P | ProSci | 0.05 mg | EUR 197.7 |
Description: (NT) West Nile Virus Envelope peptide |
West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Peptide |
|||
3441P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) West Nile Virus Envelope peptide |
West Nile Virus Matrix Antibody |
|||
24278-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Matrix Antibody |
|||
24279-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Core Antibody |
|||
24281-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Envelope Antibody |
|||
24282-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Envelope Antibody |
|||
24283-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Envelope Antibody |
|||
24284-100ul | SAB | 100ul | EUR 468 |
West Nile virus protein (Horse) |
|||
30-1261 | Fitzgerald | 250 ug | EUR 548.4 |
Description: Purified recombinant West Nile virus protein (Horse) |
West Nile Virus Envelope Protein |
|||
abx060680-100ug | Abbexa | 100 ug | EUR 794.4 |
West Nile Envelope Virus Protein |
|||
20-abx260322 | Abbexa |
|
|
West Nile Virus (WNV) Antibody |
|||
abx412023-01mg | Abbexa | 0.1 mg | EUR 610.8 |
×